Publicaciones en colaboración con investigadores/as de Vall d'Hebron Institut de Recerca (23)

2024

  1. EPITRANS. Quality assessment of the epilepsy transition process

    European Journal of Paediatric Neurology, Vol. 48, pp. 121-128

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. HIV medical care interruption among people living with HIV in Spain, 2004-2020

    AIDS, Vol. 37, Núm. 8, pp. 1277-1284

  4. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 77, Núm. 9, pp. 1273-1281

2022

  1. Corrigendum: Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors, (Front. Cardiovasc. Med, (2022), 9, (827212), 10.3389/fcvm.2022.827212)

    Frontiers in Cardiovascular Medicine

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors

    Frontiers in Cardiovascular Medicine, Vol. 9

  4. Interictal brain activity changes in temporal lobe epilepsy: A quantitative electroencephalogram analysis

    Acta Neurologica Scandinavica, Vol. 145, Núm. 2, pp. 239-248

  5. Kosaki overgrowth syndrome due to a novel de novo PDGFRB variant

    Clinical Genetics

  6. Leukodystrophy-Like Phenotype in Anti-MOG Antibody-Associated Disorders

    Neuropediatrics, Vol. 53, Núm. 2, pp. 147-148

  7. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

  8. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights

    Trials, Vol. 23, Núm. 1

2021

  1. Appropriateness of surgery performed for abdominal aortic aneurysm at tertiary hospitals in Spain

    International Angiology, Vol. 40, Núm. 4, pp. 289-296

  2. Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 9, pp. 1517-1525

  3. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

  4. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  5. Prevalence of Colorectal Neoplasms Among Patients With Enterococcus faecalis Endocarditis in the GAMES Cohort (2008–2017)

    Mayo Clinic Proceedings, Vol. 96, Núm. 1, pp. 132-146

2020

  1. An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 730-737

2019

  1. Variation in the choice of elective surgical procedure for abdominal aortic aneurysm in spain

    Vascular Health and Risk Management, Vol. 15, pp. 69-79